SCHEMBL8569200

SCHEMBL8569200

COc1ccccc1N1CCN(CC#CCN2C(=O)c3ccccc3C2=O)CC1

nearest known ligand 0.72

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DRD2 P14416 5/20 0.69
DRD3 P35462 5/20 0.69
ADRA1A P35348 3/20 0.69
ALDH1A1 P00352 2/20 0.69
ADRA1D P25100 2/20 0.69
ADRA1B P35368 2/20 0.69
CYP3A4 P08684 2/20 0.69
HTR7 P34969 2/20 0.69
MEN1 O00255 1/20 0.69
HTR1A P08908 1/20 0.69
CYP2D6 P10635 1/20 0.69
ALOX12 P18054 1/20 0.69
KMT2A Q03164 1/20 0.69
HIF1A Q16665 1/20 0.69
HSD17B10 Q99714 1/20 0.69
KDM4E B2RXH2 1/20 0.67
GLA P06280 1/20 0.67
HPGD P15428 1/20 0.67
CYP1A2 P05177 1/20 0.57
TSHR P16473 1/20 0.57

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL8570034 0.99 DRD2 (0.67) DRD2DRD3ADRA1AALDH1A1ADRA1D
SCHEMBL5800584 0.87 HTR1A (0.62) DRD2ADRA1AADRA1DADRA1BCYP3A4
Hydrochloric Acid SCHEMBL5801035 0.86 HTR1A (0.61) DRD2ADRA1AALDH1A1ADRA1DADRA1B
SCHEMBL14761789 0.85 DRD2 (0.75) DRD2DRD3ADRA1AALDH1A1ADRA1D
SCHEMBL7668612 0.84 DRD2 (0.86) DRD2DRD3ADRA1AALDH1A1ADRA1D
Nan-190 SCHEMBL29389115 0.81 HTR1A (1.00) DRD2DRD3ADRA1AALDH1A1ADRA1D
Nan-190 SCHEMBL2231820 0.81 HTR1A (1.00) DRD2DRD3ADRA1AALDH1A1ADRA1D
SCHEMBL10835973 0.81 DRD2 (1.00) DRD2DRD3ADRA1AALDH1A1ADRA1D
Nan-190 SCHEMBL30080779 0.81 HTR1A (1.00) DRD2DRD3ADRA1AALDH1A1ADRA1D
SCHEMBL8560803 0.81 DRD2 (0.59) DRD2DRD3ADRA1AALDH1A1ADRA1D

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5130315-A Treatment of psychosis Wittekind, Raymond R. (US) 1992-07-14 US claimed
EP-0494604-B1 1-Piperazinyl-2-butenes and 2-butynes, intermediates thereof, a process for their preparation and their use as medicaments HOECHST MARION ROUSSEL INC (US) 1998-10-07 EP disclosed
US-5440048-A Treating psychoses HOECHST-ROUSSEL PHARMACEUTICALS INC (US) 1995-08-08 US disclosed
US-5334715-A For treating psychological disorders HOECHST-ROUSSEL PHARMACEUTICALS INC. (US) 1994-08-02 US disclosed
US-5194436-A For trating psychosis HOECHST-ROUSSEL PHARMACEUTICALS INC. (US) 1993-03-16 US disclosed
EP-0494604-A1 1-Piperazinyl-2-butenes and 2-butynes, intermediates thereof, a process for their preparation and their use as medicaments HOECHST-ROUSSEL PHARMACEUTICALS INCORPORATED (US) 1992-07-15 EP disclosed
US-5130315-A Treatment of psychosis Wittekind, Raymond R. (US) 1992-07-14 US disclosed